• About WordPress
    • WordPress.org
    • Documentation
    • Learn WordPress
    • Support
    • Feedback
  • Log In
  • Request Membership
Skip to content
Medxy AI
  • Wellness & Lifestyle
  • Clinical Updates
  • Medical News
  • MedXY story
  • 用户
  • 登录
  • 注册
  • 会员
  • 注销
  • 账号
  • 密码重置
  • Wellness & Lifestyle
  • Clinical Updates
  • Medical News
  • MedXY story
  • 用户
  • 登录
  • 注册
  • 会员
  • 注销
  • 账号
  • 密码重置
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe
  • Home
  • weight loss
Oral Semaglutide Demonstrates Significant Weight Loss Efficacy in East Asian Adults with Overweight or Obesity: Insights from the OASIS 2 Trial
Posted inClinical Updates Wellness & Lifestyle

Oral Semaglutide Demonstrates Significant Weight Loss Efficacy in East Asian Adults with Overweight or Obesity: Insights from the OASIS 2 Trial

Posted by By MedXY 09/08/2025
The OASIS 2 trial shows oral semaglutide 50 mg significantly reduces body weight in East Asian adults with overweight or obesity, with or without type 2 diabetes, offering a promising therapeutic option with manageable safety profile.
Read More
Once-Weekly Semaglutide 2.4 mg for Obesity Management in Asian Adults: Efficacy, Safety, and Policy Insights from the STEP 11 Trial
Posted inClinical Updates Wellness & Lifestyle

Once-Weekly Semaglutide 2.4 mg for Obesity Management in Asian Adults: Efficacy, Safety, and Policy Insights from the STEP 11 Trial

Posted by By MedXY 09/07/2025
The STEP 11 trial demonstrates that once-weekly semaglutide 2.4 mg significantly reduces bodyweight in Asian adults with obesity (BMI ≥25 kg/m²), supporting its safety and guideline inclusion in these populations with unique BMI thresholds.
Read More
Advancing Obesity Management: Once-Monthly Maridebart Cafraglutide Demonstrates Significant Weight Loss Efficacy
Posted inClinical Updates Wellness & Lifestyle

Advancing Obesity Management: Once-Monthly Maridebart Cafraglutide Demonstrates Significant Weight Loss Efficacy

Posted by By MedXY 09/07/2025
Maridebart cafraglutide, a novel once-monthly peptide-antibody conjugate, significantly reduces body weight in individuals with obesity, with and without type 2 diabetes, offering a new therapeutic option based on phase 2 trial results.
Read More
CagriSema: A Breakthrough Combination Therapy for Weight Loss in Adults with Overweight or Obesity
Posted inClinical Updates Wellness & Lifestyle

CagriSema: A Breakthrough Combination Therapy for Weight Loss in Adults with Overweight or Obesity

Posted by By MedXY 08/28/2025
A phase 3a trial shows coadministered cagrilintide and semaglutide (CagriSema) significantly reduce body weight up to 20.4% over 68 weeks in adults with overweight or obesity, with manageable side effects, offering a promising new option for obesity management.
Read More
Morning or Evening? The Science Behind The Best Time to Exercise for Weight Loss and Muscle Growth
Posted inWellness & Lifestyle

Morning or Evening? The Science Behind The Best Time to Exercise for Weight Loss and Muscle Growth

Posted by By MedXY 08/22/2025
Discover how exercising at 7 AM or 7 PM can boost weight loss and muscle growth, tailored to your body's rhythms and lifestyle.
Read More
Weight Reduction Before Conception: Enhancing Fertility and Reducing Pregnancy Complications in Overweight and Obese Women
Posted inClinical Updates Wellness & Lifestyle

Weight Reduction Before Conception: Enhancing Fertility and Reducing Pregnancy Complications in Overweight and Obese Women

Posted by By MedXY 08/19/2025
A 10%-25% preconception weight loss in overweight or obese women modestly increases pregnancy likelihood and significantly lowers gestational diabetes and hypertensive complication risks, improving maternal and neonatal outcomes.
Read More
Microbiota-Mediated Weight Loss: Insights from the WLM3P Multicomponent Program in Obesity
Posted inClinical Updates Wellness & Lifestyle

Microbiota-Mediated Weight Loss: Insights from the WLM3P Multicomponent Program in Obesity

Posted by By MedXY 08/18/2025
The WLM3P weight loss program significantly remodels gut microbiota, enriching beneficial bacteria such as Faecalibacterium, which associates with improved fat and visceral fat loss in adults with obesity compared to standard low-carb diets.
Read More
Comparative Impact of 4:3 Intermittent Fasting Versus Daily Caloric Restriction on Eating Behaviors and Appetite Hormones Over 12 Months
Posted inClinical Updates Wellness & Lifestyle

Comparative Impact of 4:3 Intermittent Fasting Versus Daily Caloric Restriction on Eating Behaviors and Appetite Hormones Over 12 Months

Posted by By MedXY 08/18/2025
A 12-month trial reveals 4:3 intermittent fasting improves binge and uncontrolled eating behaviors more than daily caloric restriction, correlating with greater weight loss, while appetite hormone changes do not differ significantly between methods.
Read More
Top 10 Weight Loss Pitfalls and How to Avoid Them: A Science-Based Guide
Posted inWellness & Lifestyle

Top 10 Weight Loss Pitfalls and How to Avoid Them: A Science-Based Guide

Posted by By MedXY 08/17/2025
Uncover the ten most common weight loss misconceptions and pitfalls, and learn scientifically grounded practices to achieve sustainable, healthy fat loss.
Read More
5 Hidden Weight Gain Traps Sabotaging Your Diet — And How to Avoid Them
Posted inWellness & Lifestyle

5 Hidden Weight Gain Traps Sabotaging Your Diet — And How to Avoid Them

Posted by By MedXY 08/17/2025
Discover five common pitfalls that secretly lead to weight gain during dieting, and learn science-backed strategies for healthy, sustainable weight loss.
Read More

Posts pagination

1 2 3 Next page
  • Early-Life Blueberry Consumption: Potential Benefits for Infant Allergy Resolution, Immune Modulation, and Gut Microbiome Development
  • Unlocking Better Sleep: How Daily Walnut Consumption Enhances Melatonin Metabolism and Sleep Quality in Young Adults
  • Enhanced Therapeutic Benefits of Combined Metformin and Curcumin in Women with Polycystic Ovary Syndrome: Results from a Factorial Clinical Trial
  • Metformin with or without Mediterranean Diet Significantly Reduces Diabetes Risk in Metabolic Syndrome: Insights from the MeMeMe Trial
  • Innovative Combination Therapy in Recurrent Advanced Endometrial Cancer: Insights from the ENDOLA Phase I/II Trial
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号

  • English
  • 日本語
  • Tiếng Việt
  • 中文

aging AI Alzheimer's disease artificial intelligence atrial fibrillation blood pressure breast cancer cardiovascular health cardiovascular risk clinical trial COVID-19 depression diabetes diet dinh dưỡng exercise health heart failure HFpEF Hypertension immunotherapy longevity mental health metformin Mortality NAFLD nutrition obesity Pregnancy prevention public health randomized controlled trial randomized trial semaglutide sexual health Suy Tim sức khỏe tim mạch TAVI thử nghiệm lâm sàng Trí tuệ nhân tạo type 2 diabetes weight loss wellness women's health 心力衰竭

Your health, we care

Copyright 2025 — Medxy AI. All rights reserved.
Scroll to Top